Amylyx Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMLX and other ETFs, options, and stocks.About AMLX
Amylyx Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the provision of therapies for neurodegenerative diseases and amyotrophic lateral sclerosis (ALS). Its commercial product is Relyvrio, also known as Albrioza in Canada.
CEOJoshua B. Cohen
CEOJoshua B. Cohen
Employees123
Employees123
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2013
Founded2013
Employees123
Employees123
AMLX Key Statistics
Market cap492.06M
Market cap492.06M
Price-Earnings ratio-1.78
Price-Earnings ratio-1.78
Dividend yield—
Dividend yield—
Average volume866.33K
Average volume866.33K
High today$5.55
High today$5.55
Low today$5.33
Low today$5.33
Open price$5.39
Open price$5.39
Volume890.02K
Volume890.02K
52 Week high$7.27
52 Week high$7.27
52 Week low$1.58
52 Week low$1.58
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
14.3%
Sell
0%
People also own
Based on the portfolios of people who own AMLX. This list is generated using Robinhood data, and it’s not a recommendation.